AtriCure (ATRC) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.10 -1.73%
Revenue Growth %: +12.6%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +12.6%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $52.9 million versus the consensus estimate of $51.56 million.
GUIDANCE:
AtriCure sees FY2019 revenue of $220-228 million, versus the consensus of $223.45 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
- Lumentum shares rise on analyst upgrades, AI demand outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
